Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Respiratory Syncytial Virus, Human”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT04851977
What this trial is testing

A First in Human Study to Evaluate the Safety and Immune Response to a Vaccine for the Treatment of a Respiratory Virus, When Administered Into the Arm in Healthy Adult Participants

Who this might be right for
Respiratory Syncytial Virus Infections
Advaccine (Suzhou) Biopharmaceuticals Co., Ltd. 60
Not applicableActive Not RecruitingNCT06993753
What this trial is testing

Duration of Protection of Nirsevimab Against Hospitalisation for Respiratory Syncytial Virus Infection

Who this might be right for
Respiratory Syncytial Viral (RSV) Infections
Griffith University 4,350
Testing effectiveness (Phase 2)Study completedNCT01502072
What this trial is testing

Respiratory Syncytial Virus - RSV Protocol

Who this might be right for
Bone Marrow Transplant InfectionInfection in Marrow Transplant RecipientsRespiratory Syncytial Virus Infections+3 more
M.D. Anderson Cancer Center 48
Early research (Phase 1)Study completedNCT01556607
What this trial is testing

A Trial to Assess the Safety, Tolerability and Pharmacokinetics of MDT-637 in Subjects With Intermittent, or Mild-to-Moderate Persistent, Asthma

Who this might be right for
Drug Safety
MicroDose Therapeutx, Inc 10
Large-scale testing (Phase 3)Looking for participantsNCT07658534
What this trial is testing

Ziresovir (AK0529) in High-risk Adult With Respiratory Syncytial Virus (RSV) Infection.

Who this might be right for
Respiratory Syncytial Virus Infections
Shanghai Ark Biopharmaceutical Co., Ltd. 290
Not applicableNot Yet RecruitingNCT07445763
What this trial is testing

TARSILA Real-World Evidence Study

Who this might be right for
Respiratory Syncytial Virus (RSV)Maternal ImmunizationAcute Respiratory Illness (ARI)+2 more
Inova Medical 5,000
Testing effectiveness (Phase 2)Study completedNCT05886777
What this trial is testing

Learn About Two or More Vaccines That Are Put Together as One Shot Against Infectious Lung Illnesses, Including COVID-19 and Respiratory Syncytial Virus (RSV).

Who this might be right for
Healthy Participants
Pfizer 1,142
Testing effectiveness (Phase 2)Looking for participantsNCT06597916
What this trial is testing

RSV Vaccination in Immunocompromised Patients.

Who this might be right for
RSV Infection
Medical University of Vienna 200
Early research (Phase 1)Study completedNCT06920498
What this trial is testing

Learn How Different Amounts of the Study Medicine Called PF-07941944 Are Tolerated in the Body of Healthy Adults.

Who this might be right for
Healthy Participants
Pfizer 25
Testing effectiveness (Phase 2)Ended earlyNCT04633187
What this trial is testing

Effects of EDP-938 in Hematopoietic Cell Transplant Recipients Infected With Respiratory Syncytial Virus of the Upper Respiratory Tract

Who this might be right for
Respiratory Syncytial Virus Infections
Enanta Pharmaceuticals, Inc 9
Large-scale testing (Phase 3)Looking for participantsNCT07272434
What this trial is testing

Phase III Clinical Trial of the Recombinant Respiratory Syncytial Virus Vaccine ( CHO Cell)

Who this might be right for
Respiratory Syncytial Virus (RSV)
MAXVAX Biotechnology Limited Liability Company 25,000
Testing effectiveness (Phase 2)Study completedNCT03814590
What this trial is testing

Assess the Safety, Reactogenicity and Immune Response of GlaxoSmithKline (GSK) Biologicals' Investigational Respiratory Syncytial Virus (RSV) Vaccine (GSK3844766A) in Older Adults

Who this might be right for
Respiratory Syncytial Virus Infections
GlaxoSmithKline 1,053
Very early researchLooking for participantsNCT07106918
What this trial is testing

A Clinical Trial of SIBP-A16 Injection in Healthy Adults

Who this might be right for
Respiratory Syncytial Virus (RSV)
Shanghai Institute Of Biological Products 140
Not applicableStudy completedNCT06207929
What this trial is testing

Wearable Assisted Viral Evidence (WAVE) Study A Decentralized, Prospective Study Exploring the Relationship Between Passively-collected Data From Wearable Activity Devices and Respiratory Viral Infections

Who this might be right for
Influenza, HumanCOVID-19Influenza A+2 more
Evidation Health 18,157
Large-scale testing (Phase 3)Looking for participantsNCT06363370
What this trial is testing

Human Interferon α1b Inhalation Solution Against Respiratory Syncytial Virus in Children With Lower Respiratory Tract Infections

Who this might be right for
Respiratory Syncytial Virus Infections
Kexing Biopharm Co., Ltd. 322
Testing effectiveness (Phase 2)Study completedNCT02927873
What this trial is testing

Evaluate Safety, Reactogenicity and Immunogenicity of GSK Biologicals' RSV Investigational Vaccine Based on Viral Proteins Encoded by Chimpanzee-derived Adenovector (ChAd155-RSV) (GSK3389245A) in RSV-seropositive Infants

Who this might be right for
Respiratory Syncytial Virus Infections
GlaxoSmithKline 107
Early research (Phase 1)Study completedNCT00345670
What this trial is testing

Study to Evaluate the Safety of MEDI-534 Vaccine Against Respiratory Syncytial Virus (RSV) and Parainfluenza Virus Type 3 (PIV3) in Healthy Children

Who this might be right for
Healthy
MedImmune LLC 120
Testing effectiveness (Phase 2)Study completedNCT06251024
What this trial is testing

Study of a Respiratory Syncytial Virus Candidate Formulation in Adults Aged 60 Years and Older

Who this might be right for
Respiratory Syncytial Virus InfectionHealthy Volunteers
Sanofi Pasteur, a Sanofi Company 4,541
Testing effectiveness (Phase 2)Looking for participantsNCT06754605
What this trial is testing

Evaluate the Safety, Tolerability, and Immunogenicity of a Recombinant Respiratory Syncytial Virus Vaccine

Who this might be right for
Respiratory Syncytial Virus
Sinocelltech Ltd. 480
Large-scale testing (Phase 3)Study completedNCT06374394
What this trial is testing

A Study on the Immune Response and Safety of a Vaccine Against Respiratory Syncytial Virus (RSV) When Given Alone and Together With a COVID-19 mRNA Vaccine in Adults Aged 50 Years and Above

Who this might be right for
Respiratory Syncytial Virus Infections
GlaxoSmithKline 841
Next Page